Live Status Check

NCT05597839 Recruiting Status

Real-time enrollment status for this advanced solid tumors clinical trial

Current Status

Completed

Auto-verified from ClinicalTrials.gov

Checked: March 2, 2026 at 10:14 AM UTC

NCT05597839 Status Summary

NCT NumberNCT05597839
Recruiting StatusCompleted
ConditionAdvanced Solid Tumors
PhaseClinical Trial
Target Enrollment242 participants
Active Locations17 sites in the US
SponsorDragonfly Therapeutics
Last Updated on CT.govOctober 29, 2025 (Oct 29, 2025)

About NCT05597839 Enrollment Status

As of March 2, 2026: Clinical trial NCT05597839 is currently completed participants. This clinical trial study for advanced solid tumors is not currently accepting new participants at 17 locations across the United States. The study is sponsored by Dragonfly Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.

Frequently Asked Questions About NCT05597839

Is NCT05597839 still recruiting?

No, NCT05597839 is currently completed. The study may resume recruiting in the future.

Where is NCT05597839 recruiting?

This trial is recruiting at 17 locations in the United States. View all available locations on the full study page.

How do I enroll in NCT05597839?

Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.

When was NCT05597839 status last updated?

The official ClinicalTrials.gov record for NCT05597839 was last updated Oct 29, 2025 (October 29, 2025). HelloStudys verifies this status automatically.

Want to Learn More?

View full study details and sign up for status updates